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Improved Dynamic Response Assessment for
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J. Salaklang,2 A. Redjem,2 A. Petri-Fink,2 H. Hofmann,3 and J.-P. Vallee1
The emerging importance of nanoparticle technology, including
iron oxide nanoparticles for monitoring development, progres-
sion, and treatment of inflammatory diseases such as arthritis,
drives development of imaging techniques. Studies require an
imaging protocol that is sensitive and quantifiable for the detec-
tion of iron oxide over a wide range of concentrations. Conven-
tional signal loss measurements of iron oxide nanoparticle
containing tissues saturate at medium concentrations and show
a nonlinear/nonproportional intensity to concentration profile
due to the competing effects of T1 and T2 relaxation. A concen-
tration calibration phantom and an in vivo study of intra-articular
injection in a rat knee of known concentrations of iron oxide
were assessed using the difference-ultrashort echo time
sequence giving a positive, quantifiable, unambiguous iron sig-
nal and monotonic, increasing concentration response over a
wide concentration range in the phantom with limited suscepti-
bility artifacts and high contrast in vivo to all other tissues. This
improved dynamic response to concentration opens possibilities
for quantification due to its linear nature at physiologically rele-
vant concentrations. Magn Reson Med 68:1544–1552, 2012.
VC 2012 Wiley Periodicals, Inc.
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Early diagnostic tools and biomarkers for the detection
and determination of disease onset and for evaluating
the rapidity of disease progression as well as the ability
to gain rapid insight into the efficacy of therapeutic
interventions are essential if future drug development
and nanotechnology are to progress. Significant research
is reported in ‘‘theranostic’’ applications, in which mo-
lecular imaging is exploited for both detection of disease
and delivery of treatment (1,2). Existing diagnostic meth-
ods, namely X-ray-based techniques and magnetic reso-
nance imaging (MRI), can detect disease outcomes such
as in rheumatoid arthritis by visualizing structural dam-
age. What is needed is the ability to detect and measure
the disease process rather than morphological modifica-
tion, so we can obtain earlier diagnosis or improved
treatment monitoring. By using MRI-based molecular
imaging of injected iron oxide nanoparticles (IONs) it
should be possible to detect experimental and human ar-
thritis onset early and enable progression monitoring of
the disease and treatment responses much earlier and
more effectively, thereby minimizing irreversible joint
damage. There is an important need for the development
of rheumatoid arthritis-targeted IONs for either intrave-
nous or intra-articular (IA) injection.
Targeted molecular treatment, and its evolution with
time, needs highly sensitive and quantifiable detection
of the carrier iron oxide particles. The presence of super-
paramagnetic IONs (SPIONs) with the core size of 8–10
nm produces strong localized regions of signal loss on
conventional MR images by destroying the homogeneity
of the surrounding magnetic field. Preliminary reports
suggest the potential of MR imaging for noninvasive se-
rial monitoring, for example, in animal models of arthri-
tis (3), with cells labeled ex vivo including immune
rejection (4) and similar applications (5–7), and in vivo
uptake in inflammation and macrophage tracking (8). De-
spite the clear visibility of signal loss on the images, this
cannot easily be quantified (9,10). Problems include sim-
ilar areas of hypointense signal that can be created by
other structures in the same region, inhomogeneous
background signal, and complete saturation of the signal-
to-noise levels after an initial peak in intensity at very
low concentrations. MR sequences for positive contrast
rather than hypointense signal for iron-loaded tissue
have been the subject of intense research, as positive
contrast methods improve the detection of iron oxide-la-
beled tissue and may help to solve quantification diffi-
culties. The advantages and limitations of these positive
contrast methods for iron oxide have been reported in
the literature. These include inversion recovery with on-
resonant water suppression (11), susceptibility gradient
mapping (12), white-marker GRe Acquisition for Super-
paramagnetic Particles (GRASP) (13), and phase map
cross correlation (14). Limitations of inversion recovery
with on-resonant water suppression include loss of ana-
tomical information, necessity for projection reconstruc-
tion, off-resonance lipid effects, and sensitivity to large-
scale B0 inhomogeneity. White-marker techniques and
retrospective phase map cross correlation depend on the
orientation of the susceptibility effect with respect to B0.
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These positive contrast techniques have been shown ex
vivo, on 2D images, and with distorted signal patterns in
relation to true anatomy (15–17). A standard positive
contrast method has not yet emerged. Recently, ultra-
short echo time (UTE) imaging (18,19) has been proposed
as a technique for enhancement of localized regions of
iron uptake (20), and a three-dimensional (3D) radial UTE
sequence has been reported for cellular, brain, and skele-
tal muscle imaging (21–24). Three-dimensional UTE imag-
ing (23) uses nonselective radiofrequency and radial sam-
pling from the centre of k-space, with short read out and
TE (24). A UTE image includes signal from all tissues,
including those with very short T*2 because of the pres-
ence of iron. A second echo acquired after short T*2
decay is subtracted giving positive contrast from the iron-
containing tissue and uniform nulled background. The
difference-ultrashort echo time (dUTE) methods not only
give positive iron signal but also allow easy localization
of the signal due to maintaining background anatomy in
the individual echoes with 3D isotropic resolution. dUTE
does not require retrospective correction and is not sub-
ject to large susceptibility effects or fat/water shifts (18).
Therefore, UTE appears to be the sequence of choice for
imaging IONs. In addition to the desired TE properties,
radial imaging has a diffuse distribution of artifacts with
no wraparound, making it robust to flow and motion, and
ideal for small field-of-view (FOV) imaging.
A major problem in iron oxide imaging is quantifica-
tion of the resulting signal. Currently, little is known
about the performance of dUTE for the quantification of
iron oxide concentration, which remains extremely chal-
lenging regarding the competing effects of relaxation
times. UTE provides signal from the shortest T2 species
giving positive signal from iron, and dUTE shows unam-
biguous iron concentration response (20). T1 effects
increase signal intensity at low concentrations, followed
by signal loss at mid to high concentrations (or in the
case of clustering of particles) when T*2 dephasing sig-
nal loss becomes dominant (25,26). The competing
effects of shortened T1 and T2 will increase and decrease
signal intensity, respectively. These effects must be sepa-
rated by a sequence sensitive to either T1 or T2. By tak-
ing an UTE (T1 or proton density-like image), and one
that slightly longer, but still classically very short (T2),
the effects of the relaxation times will be isolated. The
signal remaining from even the shortest T2 species can
then be quantified using the dUTE approach.
With dUTE we, therefore, can report two related
advantages: the T2 effect in the UTE echo is isolated
from other relaxation effects by the use of a second echo,
and the information about species, such as those con-
taining iron oxide, with very short T2 is quantifiable
because of the lack of signal loss in the UTE echo. As a
precursor to studies of ION uptake in arthritis, the dose
response of new positive iron oxide contrast MR imaging
sequences and conventional MR imaging sequences was
investigated in vitro using a calibration phantom and in
vivo by IA injection in normal rat knees. After phantom
calibrations, the IA injected model was chosen as a
method to obtain in vivo images with a known concen-
tration of SPIONs as it is difficult to quantify iron oxide
in tissues after intravenous injection. This study serves
as a rationale for ‘‘theranostic" studies in arthritis models
with local delivery of drugs coupled to nanoparticles
and for particles targeted to, for example, cartilage degra-
dation via antibodies (1,3,8,27). Both noninvasive quanti-
fication of the amount of a targeted particle reaching an
anatomical location and the monitoring of kinetics for
local injection are key elements in optimizing emerging
nanoparticle studies.
METHODS
Particle Production
The SPIONs were manufactured by an aqueous copreci-
pitation method, as described previously (28). The colloi-
dal particles were further coated with a mixture of poly
(vinyl alcohol) (PVA) and vinyl alcohol/vinyl amine co-
polymer. Therefore, the particle suspension was mixed
with a solution of the polymer mixture at a weight ratio
particle/polymer of 1:9. The product will be referred to
as A-PVA-SPION in this work. The iron content of the
suspensions was determined by redox titration.
All chemicals were of analytical reagent grade and
were used without further purification. PVA (MowiolVR
3-85) with an average molecular weight of 14,000 g/mol
and a hydrolysis degree of 85% was supplied by cour-
tesy of CLARIANT (Muttenz, Switzerland). Vinyl alco-
hol/vinyl amine copolymer M12, with an average molec-
ular weight of 80,000–140,000, was supplied by courtesy
of ERKOL (Tarragona, Spain).
Dye Coupling
Surface derivatization of polymer-coated particles was
performed in the previously described magnetic bed re-
actor (29). Therefore, A-PVA-SPIONs were loaded and
immobilized in the reactor. Dye coupling was achieved
by recirculating 100 mg FluoProbes (FluoProbesVR 682,
Interchim, Montlucon, France) in 0.1 M carbonate buffer
(pH 8.3) over the immobilized nanoparticles for 2 h with
a flow rate of 1.0 mL/min. Finally, the functionalized
particles were eluted from the magnetic reactor, redis-
persed in PBS, and characterized (Table 1). Because of
technical difficulties, the fluorophore was not used in
this particular study but did not significantly change the
behavior of the particles in this application.
Transmission Electron Microscopy
Transmission electron microscopy was performed using
a Phillips (Koninklijke, Netherlands) CM-20 microscope
operating at 200 kV. For sample preparation, dilute
drops of suspensions were allowed to dry slowly on car-
bon-coated copper grids.
Particle Size
Light scattering measurements were carried out at 90 on
a photon correlation spectrometer from Brookhaven (Holz-
ville, NY) equipped with a BI-9000AT digital autocorrela-
tor. The CONTIN method was used for data processing.
The concentration of IONs was set to 100 mg iron/mL for
all measurements. The theoretical refractive index of 2.42
of magnetite was used to calculate the number-weighted
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distribution from the raw intensity-weighted data. Viscos-
ity, refractive index, and dielectric constant of pure water
were used to characterize the solvent.
Phantom Calibration
A phantom was constructed with concentrations ranging
from 12.5 to 200 mg/mL plus one water. Concentrations
are given throughout in microgram of iron per milliliter of
solution (in physiological NaCl). Scanning was carried
out on a Siemens Magnetom Trio, a Tim system, 3 T clini-
cal scanner (Siemens AG, Erlangen, Germany) with the
manufacturer’s 4-cm loop coil. The protocol parameters
included 3D T1 gradient echo (named in the article as the
Siemens acronym VIBE), with parameters repetition time
(TR)/TE 14.3/5.9 ms, flip angle 12, fat suppression, iso-
tropic resolution 0.31 mm, and FOV. dUTE consisted of
the acquisition and subtraction of two TEs (ultrashort
UTE and short TE2) leading to positive contrast from
short T2 species and reduced signal elsewhere. Parameters
here are 3D isotropic resolution matrix of 448 and 80 mm
FOV, giving a resolution of 0.18 mm in all three acquired
directions allowing freedom of reconstructed image
planes, 50,000 radial projections, UTE/TE2 0.07 ms/2.46
ms (for in-phase fat/water image), TR 9.6 ms, and flip
angle 10. All phantom tubes were scanned in the same
acquisition and, later, bandwidth and receiver gain were
kept constant for the IA in vivo images.
This was followed by a short TI inversion recovery (TI
¼ inversion time) (STIR) 2D multislice spin echo (SE)
sequence with TR/TE 3700/20 ms, flip angle 150, reso-
lution 0.156 mm, FOV 60 m, and slice thickness 1 mm.
The STIR sequence was used for comparison, as it is the
reference sequence for in vivo detection of edema. Also
included here was a third echo to use with UTE for
another dUTE image from subtraction of TE3 ¼ 4.92 ms
from the UTE echo to investigate the effect of TE on the
dUTE contrast.
The dUTE experiment was repeated at 1.5 T on a Sie-
mens Espree for comparison, with parameters as close as
allowed by the different hardware. These were 3D radial
with 50,000 radial projections, UTE/TE2/TE3 0.07 ms/
2.46 ms/4.92 ms, TR 9.6 ms, and flip angle 10.
Animal Handling and Imaging
Female Lewis rats (Janvier, Le Genest-St-Isle, France),
weighing 150–175 g (2 months old), were used through-
out this study. Fifteen rats were scanned immediately af-
ter IA injection in the knee of IONs (A-PVA-SPION) at
five different concentrations. Scanning was carried out
on a Siemens Magnetom Trio, a Tim system, 3 T clinical
scanner using the manufacturer’s 4-cm loop coil. The
protocol parameters included 3D T1 gradient echo
(named in the article as the Siemens acronym VIBE),
with parameters TR/TE 14.3/5.9 ms, flip angle 12, fat
suppression, isotropic resolution 0.31 mm, and FOV 100
mm to compare with previously published work (3) and
used in further applications of diseased knees for bone
erosion. dUTE consisted of the acquisition and subtrac-
tion of two TEs (ultrashort UTE and short TE2) leading
to positive contrast from short T2 species and reduced
signal elsewhere. Parameters here are 3D isotropic reso-
lution matrix of 448 and 80 mm FOV, giving a resolution
of 0.18 mm in all three acquired directions allowing free-
dom of reconstructed image planes, 50,000 radial projec-
tions, UTE/TE2 0.07 ms/2.46 ms (for in-phase fat/water
image), TR 9.6 ms, and flip angle 10.
Concentrations in microgram of iron per milliliter of
solution (in physiological NaCl) ranging from 12.5 to 200
mg/mL were injected for the in vivo experiments using
50 mL per knee. Concentrations were chosen to cover as
wide a range as possible after the phantom experiment
and to be realistically low so as to represent iron than
may reach the joint after systemic administration of iron
particles taking into account average blood volume.
MR imaging was carried out immediately after injec-
tion. The suturing of the joint, installation of the animal
in the MRI coil, and pilot scan took 4 min. The images
were then acquired within the next 40 min.
Animals were anesthetized with inhaled isoflurane
during imaging and monitored with a respiratory pad
(SA Instruments, Stony Brook, NY).
Image Analysis
For both phantom and in vivo images, regions were
drawn blinded with respect to concentration to quantify
the intensity of the signal in the regions containing iron
particles. For the in vivo case, homogeneous regions
within the region of iron distribution in the capsule in
the infrapatellar pouch were chosen. Standard deviation
error bars (95% confidence) are plotted for the mean
measurements over several animals.
Numerical analysis was carried out using analysis of
variance (ANOVA) with post hoc Bonferroni (PASWSta-
tistics SPSS Inc. (Chicago, IL) 18.0) and a P < 0.05 was
set as significant.
Ethical committee approval was obtained for the com-
plete protocol, and animals were kept in the institutions
animal facility with free access to food and water.
RESULTS
Phantom Calibration Curves
Phantom results allow us to assess the utility of the dif-
ferent sequences for quantifying an iron concentration
effect (Fig. 1a). At very low iron concentrations, a T1
Table 1
Particle Properties Before and After Dye Coupling
Particle
Particle
size (nm)
Zeta potential
(mV)
No. of dye
molecules/particle
Dispersing
medium
Iron concentration
(mg Fe/mL)
A-PVA-SPIONs 38.4 6 3.4 24.4 6 5.3 – Water 5
FluoProbesVR 682 conjugated
A-PVA-SPIONs
48.9 6 4.6 4.6 6 0.6 7.2 PBS 2
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effect dominates in all the gradient-echo MR sequences
including even the UTE sequence and hyperintense sig-
nal appears. At high iron concentrations, T*2 effects
induce a signal loss on all the images with the exception
of the UTE images. The resulting peak at low concentra-
tions in the 3D GRE and second echoes (TE2 and TE3)
means ambiguity in calibration. These signal loss images
also saturate to zero signal-to-noise ratio (SNR) at con-
centrations above 100 mg/mL, whereas the dUTE image
continues to distinguish concentrations twice this value.
Only with the dUTE image with a short second TE does
the monotonic increasing relation with concentration
become apparent. A longer second echo (TE3) in the
dUTE protocol gives a steeper initial slope, hence higher
sensitivity, but saturates at lower concentrations leading
to less linearity. Further problems are encountered in
vivo with this longer TE3 and are discussed below. The
difference image with the shorter second echo has a
smaller slope at low concentrations, but much better lin-
earity over a longer range. Up to 200 mg/mL of iron, the
linear fit of dUTE R2 is 0.90 for the TE2 and 0.67 for the
TE3. At physiologically relevant concentrations up to
100 mg/mL, the linear fit for dUTE is excellent with an
R2 of 0.99. The advantage of the subtraction method is
shown by these statistics to 100 mg/mL, as for the UTE,
second and third echoes of the 3D radial sequence, the
R2/p of linear regression are 0.698/0.078, 0.001/0.969,
and 0.420/0.237, with only the subtraction dUTE show-
ing a significant P < 0.002 (R2 ¼ 0.994) with the shorter
second echo, which is slightly better than using a longer
second echo, TE3 (0.967/0.003) which only performs
marginally better up to 50 mg/mL (0.995/0.05 for dUTE
with TE2 and 0.996/0.04 for dUTE with TE3) due to the
steeper initial linear slope but earlier signal saturation.
By Fisher test, the slopes for dUTE with both TE2 and
TE3 are significant compared with the regression of the
single echoes. Similar results are obtained at 1.5 T. By
comparison to the gradient-echo MR sequences, the spin
echo-based STIR sequence was characterized by a signal
drop in the synovial cavity at all the iron concentrations
as well as an early signal saturation for concentrations
more than 25 mg/mL of iron.
At 1.5 T, the dUTE curve is very similar to the curve
obtained at 3 T, with a slightly lower sensitivity (slope)
at low concentrations and is closer to linearity at the
high concentration end of the range. At 1.5 T, very simi-
lar behavior is seen as at 3 T, as the subtraction of dUTE
relies on the interplay of T1 and T2, both of which are
affected by the change in field. The sensitivity to T2 is to
be considered, but the advantages at the higher field are
more important than the slight changes in concentration
response. For the dUTE sequence, there was not an
observable difference in signal behavior at the two fields
due to the subtraction of images and the interplay of T1
and T2 effects. There was, however, with scan parame-
ters as close as possible with the differing hardware, an
advantage of around 1.4 in SNR. The plots are shown in
Fig. 1b. The T2 STIR drops to the noise level even at the
lowest concentration of 12.5 mg/mL.
In Vivo Images
In vivo images (Fig. 2) show the iron oxide in the knee
joint; however, at high concentrations, susceptibility arti-
facts (hypointense signal) become evident even in the
UTE image in the regions of high iron concentration in
the synovium (see UTE 200 mg/mL image in Fig. 2).
However, these concentrations are unlikely to be reached
with systemic injection. The VIBE sequence clearly
shows its ambiguity with high signal intensity at 12.5
mg/mL followed by signal loss. The dUTE difference
image removes this competing effect of T1 and T2 (30),
where a similar response to iron concentration is seen
for the phantom and in vivo results.
In vivo concentration effects depend on the parameters
of the different sequences. For quantification purposes,
the uniform region of iron signal in the synovium is
FIG. 1. Phantom results. Comparison of normalized signal inten-
sity versus concentration of iron oxide in sample tubes, normalized
to the signal at concentration 0 (water). Proposed dUTE method
and conventional signal loss sequences comparing sensitivity and
ambiguity at different concentrations. Normalized signal intensity
as a function of second echo time for the dUTE method showing
monotonic concentration dynamic of dUTE. a: 3 T. b: 1.5 T.
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measured; however, the concentration correlation, the
presence of susceptibility artifacts, and their effect of
expanding the apparent size of the region of iron uptake
in the VIBE sequence must be taken into account in
assessing the utility of each sequence. There is poorer sup-
pression of background in in-vivo imaging and more errors
due to increased susceptibility artifact in the second echo
if the TE is too long, reducing the feasibility for quantifica-
tion. Table 2 gives contrast (signal difference) and signal
intensity mean values for each concentration and
sequence. Statistical analysis shows contrast values and
their significance in separating different concentrations,
where P values are calculated for all the sequences sepa-
rately. A second analysis uses the signal intensity values
to assess whether any iron (grouping all the different con-
centrations together) can be distinguished from the sur-
rounding tissue in each of the sequences described. The
positive contrast overlaid on the VIBE signal loss sequence
is shown in Fig. 3 with increasing concentration. The mul-
tiple locations at different levels of intensity for the differ-
ent concentrations are clearly seen.
Figure 4 shows the comparison of the in vivo signal
intensities measured in the homogeneous region of the
infrapatellar synovium on the sequences at different con-
centrations. Here, the following observations for concen-
tration effects and tissue contrast can be made if we note
the separation and linearity of the iron signal from the
other tissues in the dUTE plot.
For the separation of different iron concentrations,
dUTE shows the expected monotonic correlation over
the range studied. VIBE signal loss shows higher sensi-
tivity at low concentrations, but saturates at a lower
value, precluding distinction of higher concentrations.
The VIBE iron signal also overlaps with other tissues
reducing contrast to zero at certain mid range concentra-
tions. The first echo UTE shows contrast of iron from the
other tissues but does not have the clear proportionality
with concentration. The in vivo intensities correlate with
concentration for dUTE with a linear fit (R2 ¼ 0.69 com-
pared with 0.49 for an exponential fit), whereas VIBE fits
better to the exponential (R2 ¼ 0.79 for the exponential
fit compared with 0.63 for a linear fit). The R2 fits show
that the dUTE fits well to a continuously increasing
function in agreement with the phantom calibration
results. VIBE always includes positive, negative, and
zero contrast as we can see from the crossing lines on
the signal intensity plots. dUTE contrast always same
sign, and therefore there are no concentrations at which
the iron signal is coincident with the surrounding mus-
cle signal.
The further advantage of dUTE becomes apparent by
comparing the contrast with the different tissues. The
iron region signal is always separated from the muscle
signal, and also, at all but the very lowest concentration,
from the bone signal. This allows easy distinction of the
size of the region of iron uptake from the surrounding
area. This is not the case for any of the classical sequen-
ces compared or the simple single echo of the UTE ac-
quisition. For VIBE, some low to intermediate concentra-
tions show no contrast from muscle, similarly for the
second and third echo of the dUTE method. This is
shown in Fig. 5 comparing contrast-to-noise ratio
between synovial iron and bone or muscle for the VIBE
and dUTE images as a function of concentration indicat-
ing the relative signal contrast and dynamic between the
different methods. Normalization of the values was done
to the noise level for calculating contrast to noise ratio
(CNR) as scaling to muscle tissue causes very different
results in the two sequences due to the bright muscle
signal in VIBE compared with the noise level muscle sig-
nal in dUTE.
Taking all the conditions together (n ¼ 15), ANOVA
(with post hoc Bonferroni) shows that only dUTE shows
significant difference between signal for synovial iron,
bone, and muscle in all cases (P < 0.013). Results from
ANOVA show contrast and separation of surrounding
tissue signal intensity and the different concentrations of
iron. For illustrative purposes, with P < 0.05 as statisti-
cally significant, there is an observed difference between
all concentrations using dUTE, but not the lower concen-
trations using VIBE. Comparing regions of muscle or
bone at different iron concentrations shows no signifi-
cant difference. We observe that contrast between iron
and bone or muscle is only different for dUTE, where
both bone and muscle signals are suppressed.
FIG. 2. In vivo results. Synovial iron on VIBE, dUTE, UTE, and
TE2 images of a control and at 50 mL volume intravenous injection
of 12.5, 50, and 200 mg/mL.
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DISCUSSION AND CONCLUSIONS
The main conclusions drawn from this study are as fol-
lows: dUTE gives a monotonic signal increase over a
greater dynamic range of concentrations than for the
other gradient-echo MR sequences including the UTE
sequence (ultrashort echo on its own). dUTE shows a
linear response of the MR signal as a function of iron ox-
ide concentration up to a physiologically relevant con-
centration of 100 mg/mL. This linear response is further
validated in vivo using a rat model of IA injections of
increasing iron oxide concentration.
Low iron oxide concentrations are detectable and
quantifiable without ambiguity, and the signal intensity
plateau (saturation) occurs at higher concentration than
signal loss/VIBE sequences. As patient doses of iron ox-
ide particles can be up to 8 mg/kg this would translate
to around 2 mg per rat. This would make a local (1 mL
volume) of 12.5–200 mg a reasonable value. Also with up
to 14 mL of contrast agent injected in patients for arthro-
scopy, the volume of 50 mL is of the same order of rela-
tive magnitude. Both the volume and concentration are
significantly lower than those used in previous animal
studies, for example, 0.5 mL of 10 mg/mL solution in
mice (31). There is a trade-off between the desired low
concentration sensitivity and the improved dynamic
response.
Three different TEs were tested with the radial 3D
sequence. The ‘‘most linear" dUTE used the shortest pos-
sible first and second echoes. A longer second echo for
the dUTE sequence would give steeper concentration
sensitivity comparable to the VIBE sequence, but intro-
duces the disadvantages of loss of contrast as the inten-
sity of bone and muscle will also change between the
two echoes and subtraction errors may occur from the
increased susceptibility artifact at longer TE. The T1
effect observed at low concentrations for the VIBE
sequence will also start coming into play, destroying the
monotonic increase leading to reduced linearity. A lon-
ger TE(1) (UTE) loses the advantages of this sequence in
detecting the shortest possible T2. The earliest possible
Table 2
Absolute Signal Intensity and Contrast Values (Defined as the Difference Between Iron and Tissue Signal Not Scaled to Noise) for
Synovial Iron Regions and Other Tissues with Statistics for Distinction of Different Concentrations of Iron and the Advantages
of dUTE for Distinction of Any Iron Concentration Signal from All Other Surrounding Tissues
Conc (lg/mL)
Signal intensitya
Contrast between synovial
iron and other tissues
dUTE VIBE UTE TE2 dUTE* VIBE* UTE* TE2*
Synovial iron 12.5 34.47 381.19 173.19 158.74
25 83.51 301.84 196.86 111.43
50 101.13 80.54 176.74 77.07
125 115.53 32.90 138.39 14.02
200 141.97 26.92 155.22 11.40
Bone 12.5 37.24 74.41 91.70 63.64 2.77 306.79 81.49 95.10
25 27.98 84.61 91.66 66.63 55.53 217.23 105.20 44.80
50 23.73 73.61 82.48 58.47 77.40 6.93 94.26 18.60
125 14.94 110.37 93.07 80.79 100.59 77.47 45.32 66.77
200 24.68 95.87 108.26 76.42 117.29 68.95 46.96 65.03
Muscle 12.5 4.66 263.16 125.85 119.18 29.81 118.03 47.34 39.56
25 1.89 303.32 129.37 128.77 81.62 1.48 67.49 17.34
50 2.63 208.63 92.14 99.67 103.76 128.09 84.60 22.59
125 3.52 240.17 100.80 99.98 119.05 207.27 37.59 85.95
200 1.97 196.92 105.62 103.01 143.94 170.00 49.60 91.62
Noise 12.5 6.03 15.62 4.52 5.94 40.50 365.57 168.67 152.79
25 0.72 15.99 4.68 5.39 84.23 285.85 192.18 106.04
50 0.35 13.00 4.84 4.79 100.78 67.54 171.90 72.28
125 0.10 15.88 4.57 4.53 115.44 17.02 133.83 9.49
200 0.93 14.42 5.18 5.05 141.04 12.50 150.04 6.35
aTaking all the concentrations together to assess which sequence best separates any iron signal from other tissue, ANOVA (with post
hoc Bonferroni) with n ¼ 15 shows the following:
 dUTE shows significant difference between signal for all synovial iron concentrations compared with surrounding bone and muscle
(all P < 0.013).
 For VIBE there is only signal difference between bone and muscle. For synovial iron signal difference to other tissues P > 0.1,
meaning iron is not separated from surrounding tissue in all cases.
 UTE has no significant difference between bone and muscle signal (P > 0.5).
 TE(2) shows no significant difference between synovial iron and bone, with a P < 0.04 for the significant difference between syno-
vial iron and muscle signal.
*P < 0.01 for contrast values comparing the different concentrations (for all values in bold). UTE synovial iron vs. noise (in italics) does
not show a significant difference between iron concentrations. This represents the ability of dUTE and VIBE to distinguish different con-
centrations of iron.
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TE(2) was chosen, with ‘‘in-phase’’ fat/water to minimize
artifacts and maximize the linear T1/T2 interplay of
dUTE. Fat sat was applied to reduce any potential fat/
water artifacts.
The nonlinearity at high concentrations may be
because, even at this short TE(1) we are not at ‘‘zero’’ TE
and at high enough concentrations some signal loss
starts to come into the effect and the first echo sequence.
The linear signal is a balance in T1 and T2 effects
between the two echoes in the difference image. This
equilibrium starts to break down at very high concentra-
tions, which are, fortunately, well above any uptake that
would result from systemic injection in a biomarker
study. The signal response is therefore still linear over
the appropriate concentration range.
In addition to the concentration effects, an important
consideration is contrast. Too much ‘‘background" tissue
signal decay occurs with a longer TE(2) reducing contrast
between iron regions. The use of the difference image,
with low signal in all but the region of iron, makes use
of SNR difficult as noise and background tissue are of
the same order of magnitude. Subtraction also gives the
consistent comparison between scans similar to taking
an SNR ratio. Because of the sharp coil profile of the
loop coil slight changes in position could cause possible
difference in SNR in the exact region of iron uptake,
although efforts were made with positioning to minimize
this.
This important contrast factor gained by the back-
ground suppression in the dUTE sequence enables the
distinction of synovial iron signal intensity from tissues
(muscle and bone) and noise, unlike any of the classical
sequences compared, or the simple single echo of the
UTE acquisition. This is illustrated by the in vivo tests
and results show separation of all tissues from regions of
iron uptake. This guaranteed separation of tissues at all
concentrations, however, must be taken in context with
the monotonic dynamic of the concentration effect. In
vivo distribution is not uniform, hence the spread of val-
ues of the three injected animals in each group. The dis-
tribution of actual concentration may vary in vivo due to
diffusion effects as discussed below. The phantom stud-
ies, however, allow calibration of any concentration
effects and show how even low concentrations can be
detected. This opens the way for automatic quantifica-
tion of signal purely from iron oxide. Contrast is higher
between iron and other tissues for dUTE than on classi-
cal sequences with several hypointense tissues. The
short echoes of the UTE and TE(2) images mean these
give a truer representation of the size of the region of
iron uptake as the sequence is less affected by suscepti-
bility artifacts (30).
However, in vivo uptake is not uniform, hence the
spread of values of the three injected animals in each
group. Because of, for example, diffusion of the injected
solution, the same injected concentration may result in
differences in local concentration. Results from ANOVA
confirm the advantages dUTE gives in terms of contrast
and quantifiable iron oxide signal. Following on from
this model, studies involving clinically relevant injec-
tion routes and timings can now be realized based on
the results of this phantom study and the feasibility
tests of known concentrations in vivo. The phantom
studies, however, allow calibration of any concentration
effects and show how even low concentrations can be
detected.
One limitation of the study is that the actual quantifi-
cation of iron is made before injection. Because of pos-
sible diffusion, the actual quantity in the image may be
slightly lower than that injected. Interference from the
skin and penetration depth did not allow optical cali-
bration from the fluorophore (as well as the fact that
free fluorophore in the agent may give an overestimated
iron oxide concentration). Another option would have
been to aspirate back the solution from the joint after
imaging although we believe that losses here may be
more than any small diffusive effect due to imaging im-
mediately after injection. If the injection was not in the
capsule, it has been observed that no signal is seen. We
can therefore assume that the signal quantified results
from complete successful injection of the contrast agent
solution.
FIG. 3. In vivo results at 50 mg/mL concentration. Iron oxide at 50
mL injected, UTE, TE(2), dUTE, dUTE fusion on anatomy and sag-
ittal for localization. The region of synovial iron is clearly
delineated. Several example slices are given throughout the knee.
Last image row shows also the contralateral knee without injec-
tion. Red is low iron signal, through yellow to white for high iron
concentration.
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Three-dimensional isotropic resolution allows recon-
struction of planes for easy registration of images with
other sequences or for registration with, for example,
histology slides. Further advantage over the highly
iron-sensitive long TE sequences is that the acquisition
time for 3D dUTE does not become prohibitively long.
Also, in the eventual application of this method in ar-
thritic joints, the competition between hyperintense
edema and hypointense synovial iron in the T2 STIR
sequence in the same region of the diseased knee
would make quantitative interpretation difficult. The
T2 STIR sequences may be of interest for the very low
dose of iron oxides particles, but it has the disadvan-
tages of saturating to zero signal intensity at very low
concentration of iron, and in a reasonable scan time it
is only possible to acquire a 2D multislice, therefore
not allowing isotropic high resolution. For very low
dose of iron, the direct analysis of the UTE images
may be of interest, and a comparison with STIR
remains to be done. Its main clinical application rele-
vant to future work in this project is detection of
edema.
In conclusion, IA injections of IONs were compared
with a concentration phantom using the dUTE sequence
that gives a positive, unambiguous synovial iron signal
and monotonic increasing concentration response over a
wide concentration range with limited susceptibility arti-
facts and high contrast to all other tissues.
FIG. 4. In vivo results showing synovial iron signal emphasizing both the sensitivity to concentration from the slope and the contrast
due to the separation of the iron data from the muscle/bone data. Non-normalized signal intensity of synovial iron region as a function
of concentration (mg/mL) of solution injected intra-articular into the knee joint of healthy rats. Signal intensity on MRI is measured imme-
diately after injection of 50 mL of solution. Top row, dUTE and VIBE; bottom row, the individual echoes for creating dUTE (UTE and
TE2). Each plot shows the effect of injected concentration on the signal intensity in the region of uptake as well as the signal for muscle
and bone in the same animals. Error bars 95%. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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FIG. 5. Contrast-to-noise (difference between synovial iron and
other tissue, normalized by noise background signal for the
appropriate sequence) between synovial iron and other tissues is
high and positive at all concentrations for the dUTE sequence
compared with VIBE. Values are shown as mean of the three ani-
mals per group with 95% error bars. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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